-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Jasper Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q3 2024.
- Jasper Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 15M shares, a 46.6% increase year-over-year.
- Jasper Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 10.4M shares, a 186% increase from 2022.
- Jasper Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.65M shares, a 68% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)